Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Issues in the adjuvant treatment of common tumors (with a focus on breast cancer) in older adults (age >70)H Wildiers
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
Triple-negative breast cancer in the older populationM Aapro, H Wildiers
ESMO Open|July 5, 2021
Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody-drug conjugates in the breast cancer treatment landscapeE Adams, H Wildiers, P Neven, et al.
Journal of the Belgian Society of Radiology|July 25, 2018
Sclerosing Lymphocytic Lobulitis Mimicking a Tumor Relapse in a Young Woman with a History of Breast CancerJ Decraene, C Van Ongeval, G Clinckemaillie, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2010
Questionnaires and instruments for a multidimensional assessment of the older cancer patient: what clinicians need to know?A G Pallis, U Wedding, D Lacombe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2009
A double-blind randomized phase II study on the efficacy of topical eye treatment in the prevention of docetaxel-induced dacryostenosisB Leyssens, H Wildiers, J P Lobelle, et al.
Disease Markers|May 3, 2007
Matrix metalloproteinase expression patterns in luminal A type breast carcinomasJ Decock, W Hendrickx, M Drijkoningen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2007
Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendationsV Launay-Vacher, E Chatelut, S M Lichtman, et al.
Breast (Edinburgh, Scotland)|December 25, 2016
Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survivalI Kindts, P Buelens, A Laenen, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2012
A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancerR Paridaens, O Rixe, M C Pinel, et al.
Pageof 9